Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CASE REPORT
Year : 2009  |  Volume : 5  |  Issue : 2  |  Page : 130-132

Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab


1 Department of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
2 Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey
3 Department of General Surgery, Faculty of Medicine, Trakya University, Edirne, Turkey
4 Department of Radiology, Faculty of Medicine, Trakya University, Edirne, Turkey

Correspondence Address:
Irfan Cicin
Medikal Onkoloji Bilim Dal?,Trakya Universitesi Hastanesi, Edirne - 22030
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-1482.52791

Rights and Permissions

The adverse effects of regimes in cancer treatment have forced us to change to new targeted therapy options. Understanding these side effects, which can lead to discontinuation of the new therapy strategies, will allow the clinical management of these side effects and result in continuing therapies with effective medications. Bevacizumab, which is an IgG1 antibody against vascular endothelial growth factor, has side effects such as proteinuria, hypertension, venous and arterial thromboembolic events, and hemorrhage. This is the first reported case of dural sinus vein thrombosis, during the treatment with bevacizumab.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5221    
    Printed146    
    Emailed1    
    PDF Downloaded426    
    Comments [Add]    
    Cited by others 6    

Recommend this journal